Dose setting assembly having features that reduce loosening - Patents.com

JP7590434B2Active Publication Date: 2024-11-26NOVO NORDISK AS
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
JP2022533126
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-12-03
Filing Date
2020-12-03
Publication Date
2024-11-26
Estimated Expiration
2040-12-03

Smart Images

  • Figure 0007590434000001
    Figure 0007590434000001
  • Figure 0007590434000002
    Figure 0007590434000002
  • Figure 0007590434000003
    Figure 0007590434000003
Patent Text Reader

Abstract

An add-on device for a medication delivery pen device, comprising: a drive member adapted to couple to a dose dial member of the pen device; a dial member adapted to rotate the drive member in a first direction and a second direction to set / adjust the pen dose; a release member axially movable to activate a pen device release button; and a linear-to-rotary converter mechanism adapted to convert axial movement of the release member into rotational movement of the drive member in the first direction, whereby when the add-on device is mounted on the medication delivery pen device, the dose dial member of the pen device is urged in the first direction by the drive member, thereby tightening up rotational slack in the pen device.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates generally to medical devices for efficient and reliable detection of an expelled dose. [Background technology]

[0002] Although the present disclosure primarily refers to drug delivery devices used to treat diabetes, for example, by subcutaneous delivery of insulin, this is merely an exemplary use of the invention.

[0003] Drug delivery devices for subcutaneous injection have greatly improved the lives of patients who need to self-administer drugs and biological agents. Such drug delivery devices may take many forms, including simple disposable devices that are nothing more than an ampoule with an injection means, or may be durable devices adapted for use with pre-filled cartridges. Regardless of their form and type, such drug injection devices have proven to be of great help in assisting patients to self-administer injectable drugs and biological agents. They also greatly assist caregivers in administering injectable medicines to those who are unable to perform self-injections. A common type of drug delivery device allows the user to set the desired dose size of the drug to be delivered. In the case of a typical mechanical device, the dose setting means is in the form of a rotatable dose setting or dial member, allowing the user to set (or "dial") the desired dose size that is then subsequently expelled from the device.

[0004] Administering the required amount of insulin injections at the right time and in the right size is essential to managing diabetes, i.e., adhering to a prescribed insulin regimen is important. To enable health care professionals to determine the effectiveness of the prescribed dosage pattern, diabetic patients are encouraged to keep a log of the size and time of each injection. However, such logs are usually recorded in handwritten notebooks, and the logged information may not be easily uploaded to a computer for data processing. Furthermore, since only events noted by the patient are logged, the note system requires the patient to remember to log each injection if the logged information is to have any value in treating the patient's disease. Missing or incorrect records in the log will result in a false picture of the injection history, which in turn will result in a false basis for the health care professional's decision-making regarding future drug treatment. Therefore, it may be desirable to automate the logging of injection information from a drug delivery system.

[0005] While some injection devices integrate this monitoring / acquisition mechanism into the device itself, as disclosed, for example, in U.S. Pat. No. 5,399,633 and U.S. Pat. No. 5,523,366, most devices today do not. The most widely used devices are simply mechanical devices that are either durable or pre-filled. The latter devices are inexpensive because they are discarded after they are emptied, and it is not cost-effective to build built-in electronic data acquisition capabilities within the device itself. To address this problem, many solutions have been proposed that would help users generate, collect, and distribute data representative of the use of a given medical device.

[0006] For example, US Pat. No. 5,999,633 describes in a first embodiment an electronic auxiliary device (also referred to as an "add-on module" or "add-on device") adapted to be releasably attached to a pen-type drug delivery device. The device includes a camera and is configured to perform optical character recognition (OCR) of an image captured from a rotating scale drum visible through a dosing window of the drug delivery device, thereby determining the dose of medicine dialed into the drug delivery device. US Pat. No. 5,999,633 discloses an electronic auxiliary device adapted to be releasably attached to a pen-type drug delivery device. The device includes a camera and is configured to determine the scale drum value based on the OCR. In order to properly determine the size of the dispensed dose, the auxiliary device further comprises additional electromechanical sensor means for determining whether the dose size is set, modified or delivered. A further external device for a pen-type device is shown in US Pat. No. 5,999,633.

[0007] Patent document 6 discloses an add-on dose logging device for a pen-type drug delivery device, comprising sensor means adapted to capture a certain amount of rotations of a magnetic member disposed within the drug delivery device, the amount of rotation of the magnetic member corresponding to the amount of drug expelled from a reservoir by the drug delivery device.

[0008] Regardless of the particular nature of the sensor means, the dose logging circuitry generally relies on determining a certain amount of rotation of a given component within the drug delivery device, the amount of rotation corresponding to the size of an expelled dose of drug for a given drug delivery device.

[0009] In view of the above, it is an object of the present invention to provide devices, assemblies and methods that allow efficient, reliable and accurate capture of an expelled dose based on determining the amount of rotation for a given indicator component or structure. The devices, assemblies and methods may relate to add-on devices adapted to be releasably mounted on a medication delivery device, as well as sensor arrangements formed integrally with a given medication delivery device. [Prior art documents] [Patent documents]

[0010] [Patent Document 1] US Patent Application Publication No. 2009 / 0318865 [Patent Document 2] International Publication No. 2010 / 052275 [Patent Document 3] International Publication No. 2014 / 037331 [Patent Document 4] International Publication No. 2014 / 020008 [Patent Document 5] International Publication No. 2014 / 161952 [Patent Document 6] International Publication No. 2019 / 057911 Summary of the Invention

[0011] In the present disclosure, embodiments and aspects are described that address one or more of the above objects or that address objects apparent from the following disclosure as well as the description of the exemplary embodiments.

[0012] The present invention is based on the realization that measuring the amount of an externally administered drug, e.g. insulin units (IU), can be done in two essentially different ways: a direct method and a (more or less) indirect method.

[0013] The unit measured on the component directly involved in the external dosing must not only be able to measure very small movements or changes in volume very accurately and very reliably, but also be very tolerant or able to compensate for, for example, variations in the positioning of an add-on measuring unit on a given drug delivery device. The component directly involved in the external dosing may be the movement of a cartridge piston or the axial movement of a piston rod.

[0014] Units measured on components that are only indirectly involved, such as the rotation of a threaded piston rod, reset tube, and other parts of the dose setting and external dosing mechanisms, usually have the advantage that larger movements and known regimes of operation need to be measured. For example, in some pen-type drug delivery devices, the piston rod is known to pivot 15° X times during external dosing (X is an integer), which means that any measurement between 40° and 50° will indicate a dose size of 3 IU.

[0015] However, looseness and small variations due to manufacturing tolerances typically creep through the mechanism, increasing measurement inaccuracies. Additionally, these units also face the challenge that the add-on unit is fitted to each injection device with some slight but varying position relative to the component being measured. In some cases, this problem is doubled, as the measured start position can vary significantly, as can the measurement of a given end position.

[0016] A major problem in fitting an add-on measuring device to an existing drug delivery device for injection is that such an add-on system needs to measure the change in position of a component from just before movement to just after movement has stopped. This means that the system will often be designed to measure the movement of a component involved in a dose setting adjustment mechanism. The dose setting adjustment mechanism is often designed to allow the user to dial up the dose size from 0 to the desired dose size, where the component is turned in a ratchet mechanism in increments of several "clicks".

[0017] Each "click" corresponds to a given volume of external medication, e.g., 1 IU or 0.5 IU, and occurs each time the component is rotated a particular number of degrees. In such ratcheting mechanisms, some play or slack between the interacting components is necessary to prevent jamming.

[0018] This means that even the worst case combination of variations in production tolerances must ensure a small amount of looseness in each interacting pair of components, so that even the combination of tight production tolerances will result in a small amount of play between the interacting parts. This further means that the opposite worst case combination will have significantly more play. Often, dial mechanisms involve interactions between 4-6 parts forming a series of machine parts, and the looseness between each interacting pair of components will gradually increase the total looseness or play of the dial mechanism. An additional 5-10 interacting components may be involved in the actual external dosing, adding to the chain of inaccuracies and looseness. Since such devices are required to be able to eject a volume with a given tolerance, the total looseness must be kept below about one third of the unit. Production costs increase significantly as production tolerances decrease, and therefore devices are primarily designed with the maximum allowable looseness to ensure that performance requirements are met. Thus, for such devices, a total looseness of up to plus / minus about one quarter of the unit is quite normal.

[0019] However, most drug delivery devices on the market today allow the user to adjust the set dose in several increments, e.g., from 0 to 80 IU. Such dose setting mechanisms therefore need to be designed so that if the user accidentally turns the dial too far or decides again to take a lower dose, they can turn the dial back to the dose size already dialed, i.e., the number of "clicks" already dialed in the ratchet mechanism, to a lower dose setting.

[0020] This means that after turning the dial up, thereby taking up all the slack on "one side", the mechanism actually moves all interacting parts from engagement on "one side" to the other side before ratcheting the dial back.

[0021] This means that the input dial, i.e. the component the user actually grabs, may need to be lifted up twice as much slack (plus / minus) which is usually not an issue for us since the user will most likely not notice the "hidden" slack when the direction of turning the dial is reversed. Additionally, some mechanisms are designed such that additional slack is introduced by a built-in mechanism during normal operation to disengage or loosen the ratchet mechanism to allow turning the dial in the opposite direction.

[0022] The above-mentioned additional slack associated with the action of turning the dial down mainly affects the input dial component, since the further down the series of interacting components is, the fewer components are affected. The actual dose expelled may not be affected at all. However, in the context of an add-on measuring device, measuring the start and end positions of a component close to the actual dial input component may present a problem, since the start position of this component may differ by up to almost a full unit, depending on how the user turned the dial up or down to reach the set dose, at the time of dose release. Even with very high measurement accuracy, it may be difficult to determine what the actual set dose was, and as a result, what was dispensed externally with an accuracy better than plus / minus one unit, and in some cases may not be able to meet the requirements of authorities for such devices.

[0023] Thus, by identifying the underlying cause of a potential lack of accuracy in a dose logging arrangement that relies on determining the rotational movement of a component "close to the dial input member," the identified problem to be solved is to provide an add-on device solution that reduces or eliminates the sensitivity of the measurement system to slack experienced by the component whose measurement is taken between the user's dialing up and dialing down actions. Indeed, such a solution may also be implemented for an integrated dose logging arrangement that utilizes the same indicator component.

[0024] Thus, in a first general aspect of the invention, an assembly is provided in which a built-in mechanism ensures that a dial-up torque is applied to a dial input component that is measured by the system prior to dose release, thereby ensuring that slack is always lifted in the same direction during measurement of the start position regardless of which direction the user last turned the dial.

[0025] In a first particular aspect of the invention, an add-on device is provided that is adapted to be releasably mounted on a drug delivery device, the drug delivery device comprising a housing defining a reference axis, a drug reservoir or means for receiving a drug reservoir, and a drug ejection means, the drug ejection means comprising a dose setting member adapted to be rotated in a first direction to incrementally set a dose and in an opposite second direction to incrementally reduce the set dose, the dose setting member being arranged at a proximal end of the housing, and a release member actuatable between a proximal position and a distal position, the proximal position allowing the dose to be set and the distal position allowing the drug ejection means to eject the set dose. The add-on device comprises an add-on housing adapted to be releasably attached to the drug delivery device housing in an axially and rotationally non-movable position, a drive member adapted to be rotationally locked mounted on the dose setting member, an add-on dose setting member that is freely rotatable but axially locked coupled to the add-on housing and adapted to be rotated in a first direction to set a dose and rotated in an opposite second direction to reduce the set dose, and an actuatable add-on release member, the actuatable add-on release member being axially rotatable relative to the add-on dose setting member between (i) a proximal dose setting position and (ii) a distal dose ejection position, in which the add-on dose setting member is operable to rotate the drive member and thereby set a dose when mounted on the dose setting member, and in which the release member moves to a distal position of the release member to release the set dose when the add-on device is mounted on the drug delivery device. The add-on device further comprises a linear-to-rotary converter mechanism adapted to convert axial movement of the add-on release member into rotational movement of the drive member in a first direction as the add-on release member moves from the proximal position towards the distal position, whereby when the add-on device is mounted on the drug delivery device, the dose setting member is biased in the first direction by the drive member as the add-on release member moves from the proximal position towards the distal position.

[0026] This arrangement can ensure that the slack in the medication delivery device dose setting mechanism can be lifted in the same direction during measurement of the starting position, regardless of which direction the user last turned the dial.

[0027] In order to prevent the rotational movement of the drive member from causing the dose setting member to move by a certain increment and thus resulting in a change in the set dose, the maximum rotational movement of the drive member should be designed to be less than the rotational movement required to change the set dose by a certain increment in a drug delivery device adapted to have an add-on device mounted thereon.

[0028] However, to achieve the above objectives, the add-on device would need to be manufactured to strict tolerances only if it were necessary to ensure that the maximum slack (with margins) of the dose setting mechanism could be less than the amount of rotation required to shift the dose setting member by a certain increment.

[0029] To address this issue, the add-on device of the exemplary embodiment includes a torque limiter that prevents torque above a pre-set level from being transmitted to the drive member when moving the add-on release member from the proximal position towards the distal position.

[0030] In this way, an add-on device can be provided which will provide with a high degree of certainty an amount of rotation of the drive member which corresponds to the maximum expected loosening of the drug ejection means and at the same time reduces the risk that the set dose is altered.

[0031] As is well known to those skilled in the art, a torque limiter is an automatic device / mechanism that protects machinery from damage due to mechanical overload or from undesired movements as disclosed above. Numerous types of torque limiters are known from machine design textbooks. For example, in an exemplary embodiment, the torque limiter may comprise a flexible element adapted to deform when a torque above a pre-set level is transmitted to the drive member. In practice, a (very) small amount of deformation will occur before the pre-set level is reached. Alternatively, the torque limiter may be in the form of a ratchet torque limiter.

[0032] In an exemplary embodiment, the rotational movement occurs by a cam-follower mechanism. It should be noted that in the context of the present invention, the term "cam-follower mechanism" covers both "conventional" embodiments in which the cam (or slot or track) member is the actively moving member and the follower is the passively moving member, as well as "reverse" embodiments in which the "follower" is the actively moving member and the cam member is the passively moving member. Alternatively, the linear-to-rotary converter mechanism may comprise "free" ramps which move relative to each other.

[0033] In certain embodiments, the cam-follower mechanism includes a track and a follower disposed within the track, the track having a radial component, and the follower and track move axially relative to one another as the add-on release member moves from a proximal position toward a distal position.

[0034] In certain embodiments, the follower comprises a flexible arm adapted to bend when a torque above a preset level is imparted to the drive member, thereby providing a cam-follower mechanism with an integrated torque limiter.

[0035] Alternatively, the torque limiter that prevents a rotational force above a predetermined level from being applied to the dose setting member via the drive member is a ratchet torque limiter, i.e. a clutch that will slip or "jump" when the desired amount of torque is applied.

[0036] Regardless of the particular design of the linear-to-rotary converter mechanism and the torque limiter, the drug ejection means may comprise an indicator adapted to rotate during ejection of a dose, the amount of rotation being indicative of the size of the ejected dose. Accordingly, the add-on device comprises a sensor means operable to detect the amount of rotation of the indicator during ejection of a dose. Before the sensor means operates, it may be ensured that rotational slack in the drug ejection means has been removed by rotation of the dose setting member in the direction turning the first dial up when the linear-to-rotary converter mechanism is activated.

[0037] In an exemplary embodiment, the add-on device comprises an actuator structure adapted to move axially and engage with the release member when the add-on release member is actuated, and an electronic sensor circuit is coupled to the actuator structure and moves axially therewith. The actuator structure may be in the form of an electronic assembly, e.g. a unit or module comprising the electronic sensor circuit in the form of a sensor component, a processor, a memory, wireless communication means and a battery.

[0038] Alternatively, the medication delivery device may be adapted to fit a dose logging add-on device comprising sensor means operable to detect the amount of rotation of an indicator during ejection of a dose, for example in the form of numbers on a scale drum.

[0039] In certain embodiments, the indicator comprises a plurality of dipole magnets and the sensor means comprises a plurality of magnetometers arranged in a non-rotational orientation relative to the housing when mounted and adapted to determine values ​​of a magnetic field from the plurality of dipole magnets, and a processor means configured to determine a rotational position and / or rotational movement of the indicator based on measurements from the plurality of magnetometers. Such sensor means may be incorporated within a loosening resistant add-on device or a separate additional sensor add-on device.

[0040] In a further aspect of the present invention, there is provided an assembly comprising a drug delivery device and a corresponding add-on device as disclosed above.

[0041] In yet a further aspect of the invention there is provided an integrated drug delivery device with integrated locking means as disclosed above, comprising a housing defining a reference axis, a drug reservoir or means for receiving a drug reservoir, and drug ejection means comprising an inner dose setting member adapted to be rotated in a first direction to set a dose and in an opposite second direction to reduce the set dose, an inner release member actuatable between a proximal position and a distal position, the proximal position allowing the dose to be set and the distal position allowing the drug ejection means to eject the set dose, and an indicator adapted to rotate during ejection of the dose, the amount of rotation indicating the size of the ejected dose. The device further comprises a user dose setting member, freely rotatable but axially locked, coupled to the housing and adapted to rotate in a first direction to set a dose and rotate in an opposite second direction to decrease the set dose, an actuatable user release member axially rotatable relative to the user dose setting member between (i) a proximal dose setting position and (ii) a distal dose ejection position, in which the user dose setting member is operable to rotate the inner dose setting member to set a dose, and in which the inner release member moves to a distal position of the inner release member to release the set dose, and a linear-to-rotary converter mechanism adapted to convert an axial movement of the user release member into a rotational movement of the inner dose setting member in the first direction when the user release member moves from the proximal position towards the distal position, whereby the inner dose setting member is biased in the first direction when the drug ejection means is released. The biasing force applied to the inner dose setting member can be controlled by a torque limiter up to a maximum level that ensures that the set dose is not altered.

[0042] The drug delivery device may comprise an integrated sensor means operable to detect the amount of rotation of the indicator during the ejection of a dose. Alternatively, the drug delivery device may be adapted to mount a dose logging add-on device comprising sensor means operable to detect the amount of rotation of the indicator during the ejection of a dose.

[0043] In certain embodiments, the indicator comprises a plurality of dipole magnets, and the sensor means, when mounted, comprises a plurality of magnetometers disposed in a non-rotational orientation relative to the housing and adapted to determine values ​​of a magnetic field from the plurality of dipole magnets, and processor means configured to determine a rotational position and / or rotational movement of the indicator based on measurements from the plurality of magnetometers.

[0044] Regardless of the particular design of the biasing arrangement, the drug ejection means may comprise an indicator adapted to rotate during ejection of a dose, the amount of rotation being indicative of the size of the ejected dose. Accordingly, the add-on device comprises sensor means operable to detect the amount of rotation of the indicator during ejection of a dose. Before the sensor means operates, it may be ensured that rotational slack in the drug ejection means has been removed by rotation of the dose setting member in the first dial up direction when the linear-to-rotary converter mechanism is activated.

[0045] As used herein, the term "insulin" is meant to encompass any drug-containing flowable pharmaceutical product, such as a liquid, solution, gel, or fine suspension, that can be passed in a controlled manner through a delivery means, such as a cannula or hollow needle, and that has a glycemic control effect, e.g., human insulin and its analogs, as well as non-insulins such as GLP-1 and its analogs. In the description of the exemplary embodiment, reference is made to the use of insulin, however, the described modules can also be used to generate logs for other types of drugs, such as growth hormone.

[0046] Hereinafter, an embodiment of the present invention will be described with reference to the drawings. [Brief description of the drawings]

[0047] [Figure 1A] FIG. 1A shows a pen-based device. [Figure 1B] FIG. 1B shows the pen device of FIG. 1A with the pen cap removed. [Diagram 2] FIG. 2 shows an exploded view of the components of the pen device of FIG. 1A. [Figure 3A-3B] 3A and 3B show cross-sectional views of the ejection mechanism in two states. [Figure 4A-4B] 4A and 4B show schematic representations of an add-on device and a drug delivery device. [Figure 5A-5B] 5A and 5B respectively show the exemplary drug delivery device shown in FIG. 4B and a corresponding add-on device adapted to be mounted thereon. [Figure 6A] FIG. 6A shows, in partial perspective view, a first embodiment of an add-on dose logging device with a locking mechanism. [Figure 6B] FIG. 6B shows the add-on device of FIG. 6A in a cross-sectional view. [Figure 7A-7D] 7A-7D show individual components that form part of the add-on device of FIG. 6A. [Figure 8A-8H] 8A-8H show, in partially cut away representations, the add-on device of FIG. 6A in different operational states when mounted on the drug delivery device of FIG. 5A. [Figure 9A] FIG. 9A shows a second embodiment of an add-on dose logging device with a locking mechanism. [Figure 9B] FIG. 9B shows the inner assembly of the add-on device of FIG. 9A. [Figure 9C] FIG. 9C shows the add-on device of FIG. 9A in a cross-sectional view. [Figure 10A-10D] 10A-10D show individual components that form part of the add-on device of FIG. 9A. [Figures 11A-11E] 11A-11E show, in partially cut away representations, the add-on device of FIG. 9A in different operational states when mounted on the drug delivery device of FIG. 5A. [Figure 12] FIG. 12 shows the assembly of FIG. 11A in an alternative representation and view. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0048] In the drawings, like structures are primarily identified with like reference numbers.

[0049] When the following terms, such as "upper" and "lower", "right" and "left", "horizontal" and "vertical", or similar relative expressions, are used, they refer only to the attached figures and do not necessarily show the actual situation of use. The figures shown are schematic representations, so that the configuration of the different structures as well as their relative dimensions are intended to serve only illustrative purposes. When the term member or element is used for a given component, this generally represents that this component is an integral component in the described embodiment, but alternatively, the same member or element may include several subcomponents, such that two or more of the described components may be provided as an integral component, for example, may be manufactured as an integral injection molded part. The term "assembly" does not imply that the described components need to be assembled to provide an integral or functional assembly during a given assembly procedure, but is merely used to describe components that are grouped together as more closely related functionally.

[0050] Before returning to embodiments of the invention itself, one example of a pre-filled drug delivery device will be described, as such a device provides a basis for exemplary embodiments of the invention. The pen-type drug delivery device 100 shown in Figures 1-3 may represent a "generic" drug delivery device, and the device actually shown is a FlexTouch® pre-filled drug delivery pen manufactured and sold by Novo Nordisk A / S, Bagsvaerd, Denmark.

[0051] The pen device 100 comprises a main part having a cap part 107, a proximal body or drive assembly part having a housing 101 in which a drug ejection mechanism is disposed or integrated, and a distal cartridge holder part in which a drug-filled transparent cartridge 113 having a distal needle-penetrable septum is disposed and held in place by a non-removable cartridge holder attached to the proximal part, the cartridge holder having an opening allowing a portion of the cartridge to be inspected, as well as a distal connection means 115 allowing a needle assembly to be releasably attached. The cartridge is provided with a piston driven by a piston rod forming part of the ejection mechanism, and may contain, for example, an insulin, GLP-1 or growth hormone preparation. A proximal-most rotatable dose setting member 180 having a number of axially oriented grooves 188 serves to manually set a desired dose of drug which is shown in the display window 102 and which can then be ejected when a button 190 is actuated. As will become apparent from the following description, the axially oriented grooves 188 shown may be referred to as "drive grooves". The dose setting member 180 has a generally cylindrical outer surface 181 (i.e. the dose setting member may be slightly tapered) and in the embodiment shown the outer surface is textured by providing a plurality of axially oriented microgrooves to improve finger grip during dose setting. The window is in the form of an opening in the housing surrounded by the chamfered edge portion 109 and the dose pointer 109P, the window allowing observation of a portion of the helically rotatable indicator member 170 (scale drum). Depending on the type of ejection mechanism embodied in the medication delivery device, the ejection mechanism may comprise a spring that is deformed during dose setting and subsequently released when a release button is actuated to drive the piston rod, as in the embodiment shown.Alternatively, the ejection mechanism may be fully manual, in which case the dose member and actuation button are moved proximally during dose setting corresponding to the set dose size and then moved distally by the user to eject the set dose, as for example in the FlexPen® manufactured and sold by Novo Nordisk A / S.

[0052] Although FIG. 1 shows a drug delivery device of a pre-filled type, i.e. which is supplied with a pre-attached cartridge which is discarded when the cartridge is emptied, in alternative embodiments the drug delivery device may be designed to be replaced with a filled cartridge, e.g. in the form of a "rear-loading" drug delivery device in which the cartridge holder is adapted to be detached from the main part of the device, or alternatively in the form of a "front-loading" device in which the cartridge is inserted through a distal opening into a cartridge holder which is non-removably attached to the main part of the device.

[0053] Since the present invention relates to electronic circuitry adapted to interact with a drug delivery device, an exemplary embodiment of such a device will be described for a better understanding of the invention.

[0054] Figure 2 shows an exploded view of the pen-type drug delivery device 100 shown in Figure 1. More specifically, the pen comprises a tubular housing 101 having a window opening 102, on which a cartridge holder 110 is fixedly mounted, with a drug-filled cartridge 113 disposed within the cartridge holder. The cartridge holder is provided with distal connection means 115 allowing a needle assembly 116 to be releasably mounted thereon, and proximal connection means in the form of two opposed projections 111 allowing a cap 107 to be releasably mounted over the cartridge holder and the attached needle assembly, and a projection 112 preventing the pen from rolling, for example on a table top. Fixedly mounted to the housing distal end is a nut element 125, which comprises a central threaded bore 126, and fixedly mounted to the housing proximal end is a spring base member 108 having a central opening. The drive system includes a threaded piston rod 120 having two opposing longitudinal grooves and received in a threaded bore of the nut element, a piston rod drive element 130 in the form of a ring rotationally disposed in the housing, and a clutch element 140 in the form of a ring in rotational engagement with the drive element (see below), which engagement allows axial movement of the clutch element. The clutch element is provided with an outer spline element 141 adapted to engage with corresponding splines 104 (see FIG. 3B) on the inner surface of the housing, which allows the clutch element to move between a rotationally locked proximal position in which the splines are engaged and a rotationally free distal position in which the splines are disengaged. As just mentioned, in both positions the clutch element is rotationally locked relative to the drive element. The drive element comprises a central bore with two opposing projections 131 in engagement with the grooves of the piston rod, whereby rotation of the drive element results in rotation of the piston rod and thereby in distal axial movement, due to the threaded engagement between the piston rod and the nut element. The drive element further includes a pair of opposed, circumferentially extending flexible ratchet arms 135 adapted to engage corresponding ratchet teeth 105 disposed on the housing inner surface.The drive element and clutch element are provided with cooperating coupling structure that rotationally locks them together but allows the clutch element to move axially to its distal position where it can rotate, thereby transmitting rotational movement from the dial system (see below) to the drive system. The interaction between the clutch element, drive element, and housing is shown and described in more detail with reference to Figures 3A and 3B.

[0055] An end of content (EOC) member 128 is threaded onto the piston rod and rotationally mounted on its distal end is a washer 127. The EOC member includes a pair of opposed radial projections 129 for engaging the reset tube (see below).

[0056] The dial system includes a ratchet tube 150, a reset tube 160, a scale drum 170 having a pattern forming a row indicating the dose arranged in an external spiral, a dial member 180 operated by a user to set the dose of the drug to be dispensed, a release button 190, and a torque spring 155 (see FIG. 3). The dial member is provided with a circumferential inner tooth structure 181 that engages with a number of corresponding outer teeth 161 arranged on the reset tube, providing a dial interlock that is engaged when the reset tube is in a proximal position during dose setting and disengaged when the reset tube moves distally during dose ejection. The reset tube is axially locked and mounted inside the ratchet tube, but can rotate a few degrees (see below). The reset tube includes two opposing longitudinal grooves 169 on its inner surface adapted to engage the radial projections 129 of the EOC member, thereby allowing the EOC to rotate with the reset tube but move axially. The clutch element is axially locked and mounted on the outer distal end portion of the ratchet tube 150, allowing the ratchet tube to move axially into and out of rotational engagement with the housing via the clutch element. The dial member 180 is axially locked and mounted but rotationally free on the housing proximal end, and the dial ring is, under normal operation, rotationally locked to the reset tube (see below), whereby rotation of the dial ring results in corresponding rotation of the reset tube 160, and thereby the ratchet tube. The release button 190 is axially locked to the reset tube, but is free to rotate. A return spring 195 provides a proximally directed force on the button and the reset tube mounted thereto.A scale drum 170 is disposed in the circumferential space between the ratchet tube and the housing, the drum being rotationally locked to the ratchet tube via cooperating longitudinal splines 151, 171 and in rotational threaded engagement with an inner surface of the housing via cooperating thread formations 103, 173 so that a row of numbers passes through a window opening 102 in the housing as the drum is rotated relative to the housing by the ratchet tube. A torque spring is disposed in the circumferential space between the ratchet tube and the reset tube and is secured at its proximal end to the spring base member 108 and at its distal end to the ratchet tube so that the spring is deformed when the ratchet tube is rotated relative to the housing by rotation of the dial member. A ratchet mechanism is provided having a flexible ratchet arm 152 between the ratchet tube and the clutch element, the clutch element being provided with a circumferential internal tooth structure 142, each tooth providing a ratchet stop such that the ratchet tube is held in the position to which it has been rotated by the user via the reset tube when the dose has been set. To allow for reduction of the set dose, a ratchet release mechanism 162 is provided on the reset tube and acts on the ratchet tube, which allows the set dose to be reduced by one or more ratchet notches by pivoting the dial member in the opposite direction, the release mechanism being actuated when the reset tube is rotated the aforementioned number of degrees relative to the ratchet tube.

[0057] Having described the different components of the ejection mechanism and their functional relationships, the operation of the mechanism will now be described, primarily with reference to Figures 3A and 3B.

[0058] The pen mechanism can be considered as two interacting systems, the dose system and the dial system, as described above. During dose setting, the dial mechanism rotates and loads the torsion spring. The dose mechanism is locked to the housing and cannot move. When the push button is pressed, the dose mechanism is released from the housing and due to its engagement with the dial system, the torsion spring now rotates the dial system back to the starting point and also rotates the dose system with it.

[0059] The central part of the dose mechanism is the piston rod 120, by which the actual displacement of the plunger is performed. During dose delivery, the piston rod is rotated by the drive element 130, and the piston rod moves forward in the distal direction due to the threaded interaction with a nut element 125 fixed to the housing. Between the rubber piston and the piston rod, a piston washer 127 is placed, which acts as an axial bearing for the rotating piston rod and equalizes the pressure on the rubber piston. The piston rod has a non-circular cross section, which allows the piston rod drive element to engage with the piston rod, so that the drive element is rotationally locked to the piston rod but moves freely along the piston rod axis. As a result, rotation of the drive element results in a linear forward movement of the piston. The drive element is provided with a small ratchet arm 134 that prevents the drive element from rotating clockwise (as viewed from the end of the push button). Due to the engagement with the drive element, the piston rod can therefore only move forward. During dose delivery, the drive element rotates counterclockwise and the ratchet arm 135 also provides a small click sound to the user by engaging the ratchet teeth 105, for example one click per unit of insulin expelled.

[0060] Turning to the dial system, the dose is set and reset by pivoting the dial member 180. When the dial is pivoted, the reset tube 160, EOC member 128, ratchet tube 150, and scale drum 170 all pivot with the dial due to the dial linkage being in an engaged state. The ratchet tube is connected to the distal end of the torque spring 155, which loads the spring. During dose setting, the ratchet arm 152 performs a dial click for each unit the dial is turned due to interaction with the internal tooth structure 142 of the clutch element. In the embodiment shown, the clutch element is provided with 24 ratchet stops that provide 24 clicks (notches) for a full 360 degree rotation relative to the housing. The spring is preloaded during assembly, which allows the mechanism to deliver both small and large doses within acceptable speed intervals. The scale drum is rotationally engaged with the ratchet tube but is axially movable, and the scale drum is threadably engaged with the housing so that as the dial system rotates, the scale drum moves in a spiral pattern and a number corresponding to the set dose is displayed in the housing window 102.

[0061] The ratchet 152, 142 between the ratchet tube and the clutch element 140 prevents the spring from pivoting the part back. During reset, the reset tube moves the ratchet arm 152, thereby releasing the ratchet with each click, one click corresponding to 1 IU in the described embodiment. More specifically, when the dial member is pivoted clockwise, the reset tube simply rotates the ratchet tube, allowing the arm of the ratchet to freely interact with the tooth structure 142 of the clutch element. When the dial member is pivoted counterclockwise, the reset tube directly interacts with the ratchet click arm, pushing the click arm away from the teeth in the clutch and towards the center of the pen, thus allowing the click arm on the ratchet to move "one click" backwards due to the torque created by the loaded spring.

[0062] To deliver the set dose, the push button 190 is pushed distally by the user, as shown in FIG. 3B. The dial linkages 161, 181 are disengaged and the reset tube 160 is disengaged from the dial member, after which the clutch element 140 is disengaged from the housing spline 104. The dial mechanism now returns to "zero" together with the drive element 130, which leads to a dose of drug being expelled. It is possible to stop and start the dose at any time during drug delivery by releasing or pressing the push button. Doses below 5 IU usually cannot be paused, as the rubber piston is compressed too quickly, which leads to compression of the rubber piston, followed by delivery of insulin when the piston returns to its original dimensions.

[0063] The EOC feature prevents the user from setting a dose larger than what is left in the cartridge. The EOC member 128 is rotationally locked to the reset tube, which allows the EOC member to rotate during dose setting, resetting, and dose delivery while it can move axially back and forth following the threads of the piston rod threads. When the proximal end of the piston rod is reached, a stop is provided, which prevents all connected parts, including the dial member, from further rotating in the dose setting direction, i.e., the set dose now corresponds to the remaining drug content in the cartridge.

[0064] The scale drum 170 is provided with a distal stop surface 174 adapted to engage a corresponding stop surface on the housing inner surface, which provides a maximum dose stop for the scale drum and prevents all connected parts, including the dial member, from being rotated further in the dose setting direction. In the embodiment shown, the maximum dose is set at 80 IU. Correspondingly, the scale drum is provided with a proximal stop surface adapted to engage a corresponding stop surface on the spring base member, which prevents all connected parts, including the dial member, from being rotated further in the dose ejection direction, thereby providing a "zero" stop for the entire ejection mechanism.

[0065] The EOC member functions to provide a security system to prevent accidental overdosing if there is any obstruction in the dial mechanism, allowing the scale drum to move beyond the zero position. More specifically, in the initial state with a full cartridge, the EOC member is positioned in an axially most distal position in contact with the drive element. After a given dose has been expelled, the EOC member is again positioned to contact the drive element. In response, the EOC member locks against the drive element if the mechanism attempts to deliver a dose beyond the zero position. Due to the tolerances and flexibilities of the various parts of the mechanism, a small "overdose" of medication (e.g., 3-5 IU of insulin) may be expelled by the EOC traveling a short distance.

[0066] The ejection mechanism further includes an end of dose (EOD) click function that provides clear feedback at the end of the ejected dose to inform the user that the entire amount of medication has been ejected. More specifically, the EOD function is achieved by the interaction between the spring base and the scale drum. As the scale drum returns to zero, a small click arm 106 on the spring base is forced backwards by the advancing scale drum. Just before "zero", the arm is released and hits a countersunk surface on the scale drum.

[0067] The mechanism shown is further provided with a torque limiter to protect the mechanism from overloads applied by the user via the dial member. This function is provided by an interface between the dial member and the reset tube, which are rotationally locked to one another as described above. More specifically, the dial member is provided with a circumferential internal tooth structure 181 that engages with a number of corresponding external teeth 161, which are arranged on the flexible carrier part of the reset tube. The reset tube teeth are designed to transmit a given specified maximum size of torque (e.g. 150-300 Nmm) above which the flexible carrier part and the teeth bend inwards, allowing the dial member to pivot without rotating the rest of the dial mechanism. The inner mechanism of the pen is therefore not stressed with loads higher than what the torque limiter transmits via the teeth.

[0068] Having explained the principles of operation of the mechanical drug delivery device, embodiments of the present invention will now be described.

[0069] Figures 4A and 4B show schematic diagrams of a first assembly of a pre-filled pen-shaped drug delivery device 200 and an add-on dose logging device 300 adapted therefor. The add-on device is adapted to be mounted on a proximal end portion of the pen device housing and is provided with dose setting and dose releasing means 380 that cover corresponding means on the pen device in the mounted state shown in Figure 4B. In the embodiment shown, the add-on device comprises a coupling part 385 adapted to be axially mounted and rotationally locked on the drug delivery housing. The add-on device comprises a rotatable dose setting member 380, which is directly or indirectly coupled to the pen dose setting member 280 such that during dose setting, the rotational movement of the add-on dose setting member is transferred to the pen dose setting member in either direction. In order to reduce external influences during dose ejection and dose sizing, the outer add-on dose setting member 380 can be rotationally decoupled from the pen dose setting member 280 during dose release and ejection. The add-on device further includes a dose release member 390 that can move distally, thereby actuating the pen release member 290.

[0070] 5A and 5B, a first exemplary specific embodiment of an add-on dose logging device 500 adapted to be mounted on a pen-type drug delivery device 400 is shown, the pen-type device essentially corresponds to a FlexTouch® pre-filled drug delivery pen, the add-on dose logging device shown is branded as "Dialoq®". The add-on device 500 essentially corresponds to the add-on dose logging device 300 described above, and therefore comprises a housing part 585 adapted to be axially mounted and rotationally locked on the drug delivery housing via a releasable coupling means 586, the housing comprising a window 587 allowing the pen-type scale drum 470 to be observed during dose setting. The add-on device comprises a rotatable dose setting member 580 coupled to the pen-type dose setting member 480 during dose setting, so that the rotational movement of the add-on dose setting member is transferred to the pen-type dose setting member in either direction. The add-on device further comprises a dose release member 590 that can move distally and thereby actuate the pen-type release member 490.

[0071] To determine the size of the dispensed dose of medication, the pen device may be equipped with a magnetic identifier adapted to rotate during dose ejection, and accordingly the add-on device may be equipped with a sensor circuit capable of capturing the amount of rotation and thereby determining the dispensed dose size. Some embodiments based on this concept are disclosed and described in detail in WO 2019 / 162235, which is incorporated herein by reference.

[0072] In summary, the add-on device disclosed in WO 2019 / 162235 comprises an outer assembly releasably attachable to a medication delivery device housing, and an inner assembly. The outer assembly comprises an add-on dose setting member 580 and an add-on release member 590 axially movable relative to the add-on dose setting member between a dose setting state and a dose ejection state. The inner assembly comprises an inner dose setting member adapted to engage with the dose setting member 480, a sensor means adapted to detect the amount of rotation of the indicator during the ejection of a dose, and an actuator coupled to the add-on release member and axially movable relative to the inner dose setting member between a proximal position and a distal position, the actuator adapted to engage and actuate the pen device release member 490 when moved distally. For example, a sensor circuit in the form of an electronic module may form part of the actuator (and thus move axially with the actuator) and may be non-rotationally coupled to the inner dose setting member to prevent rotation during the ejection of a dose. The sensor circuitry will typically be awakened from a sleep state when a user actuates the add-on release member 590 causing it to move axially.

[0073] By identifying the underlying cause of the potential lack of accuracy in the dose logging arrangement, as discussed above, depending on determining the rotational movement of a component "close to the dial input member", the identified problem to be solved is to provide an add-on device solution that reduces or eliminates the sensitivity of the measurement system to loosening experienced by the component where the measurement is taken (e.g., an indicator member comprising a magnet) between the user's turning the dial up and turning the dial down.

[0074] Accordingly, in the following exemplary embodiment, an assembly is provided in which a built-in mechanism ensures that a dial-up torque is applied to the dial input component that is measured by the system before dose release, thereby ensuring that slack is always lifted in the same direction during start position measurement regardless of which direction the user last turned the dial.

[0075] 6A and 6B, a first exemplary embodiment of a locking mechanism suitable for incorporation into an add-on dose logging device of the general type disclosed in FIG. 5B is described.

[0076] 6A shows, in a partial "see-through" view, an add-on dose logging device 600 comprising an outer assembly (shown in "see-through") and an inner assembly coupled thereto. The outer assembly comprises a housing member 610 adapted to be coupled to a pen housing, an add-on dial member 680 rotationally coupled to the housing member 610, and an add-on dose ejection member (button) 690. The inner assembly comprises a drive member 650 adapted to non-rotationally engage with the pen device dial member, a rotor member 660 arranged to transfer rotational movement from the dial member 680 to the drive member 650 during dose setting and to provide locking rotation during dose release, and an electronic sensor assembly (ESA) 670 (see FIG. 6B) disposed within the hollow interior of the rotor member 660. In FIG. 6B, the ESA 670 is shown disposed inside the rotor member, the latter having an opening at its proximal end that allows a fixing pin 675 to connect the add-on release member 690 to the ESA 670, so that all parts can rotate and move slightly axially relative to one another.

[0077] Before describing the operating principle of the add-on device 600, the individual cooperating components will be described in more detail.

[0078] In Fig. 7A, a housing member 610 is shown having a generally tubular configuration. The distal end comprises coupling means (not shown) adapted to fixedly but releasably engage corresponding coupling means on the pen body. The proximal portion comprises a circumferential groove 611 and several axially oriented slots onto which the dial member 680 can be snapped. The inner surface of the housing member comprises a circumferential array of protrusions 615 adapted to engage corresponding protrusions on the rotor member during operation, as well as a circumferential flange 613 (see Fig. 8A) for rotationally supporting the drive member 650 during dose setting.

[0079] The generally cylindrical dial member 680 shown in Figure 7B comprises a distal inner circumferential flange 681 (see Figure 8A) adapted to be rotatable in both directions about a central axis whilst being axially fixed within the groove 611 of the housing member. A circumferentially disposed protrusion 686 on the inside of the dial member near the proximal end is adapted to engage the rotor member 660 and to transmit rotational movement from the dial member to the rotor member when the dose release member 690 is fully released. The dial member further comprises a circumferential recess 682 in which the dose release push button 690 can be fixedly mounted and axially guided (by a coupling means not shown) and in which a coil return spring 640 (see Figure 6B) for the dose release member can be accommodated.

[0080] The generally cup-shaped rotor member 660 shown in FIG. 7C comprises a proximal disc-shaped portion and a distally extending generally cylindrical skirt portion. The skirt portion comprises several (here three) distally extending flexible arms 661 each having at a distal end an inwardly projecting generally cylindrical follower structure 662 adapted to engage a corresponding slot / race structure 652 in the drive member 650, the arms acting initially to transmit rotational movement and thereafter to absorb excess rotational movement, thereby providing a controlled amount of torque to absorb slack, as described in more detail below. The rotor member 660 comprises a proximally disposed circumferential tooth pattern 666 adapted to engage and disengage from the protrusions 686 of the dial member during operation. At the distal end, the rotor member comprises a circumferential array of protrusions 665 arranged to engage and disengage from protrusions 615 of the housing member, thereby locking the rotor member rotationally, but not axially, during operation. The disc-shaped portion comprises a central opening 667 which serves to keep the ESA axially centred via a fixing pin 675. Friction surfaces 668 surrounding the openings on both sides enable the dose release member and ESA to act as brake pads and rotationally lock the rotor member and ESA to one another when the dose release member 690 and ESA are pressed against the friction surfaces from each side.

[0081] The drive member 650 shown in Fig. 7D comprises a proximal generally cylindrical portion 651 from which extend distally a number of axially oriented drive fingers 658 adapted to engage with pen dial grooves 488 (see Fig. 5A) and thereby rotationally lock the drive member to the pen dial member 480. The proximal portion comprises a number (here three) of proximally open non-linear slots / tracks 652 adapted to receive and axially guide rotor flexible arm followers 662. The proximal portion further comprises a number of circumferentially arranged guide structures 653 adapted to slidingly engage with the inner wall surface of the housing as well as with the proximally oriented support surface of the circumferential flange 613, thereby ensuring centering within the housing during rotational movement of the drive member.

[0082] The operation of the add-on device 600 will be described with reference to FIGS. 8A to 8H.

[0083] Generally, all of Figures 8A-8H show, in a partially cut-away view, the add-on device 600 of Figure 6A mounted on the pen-type drug delivery device 400 of Figure 5A, with the add-on housing member 610 mounted on the pen housing 410 and the add-on driver 650 rotationally coupled to the pen dial member 480 via a distally extending arm 658.

[0084] More specifically, it should be noted that the housing member 610, the add-on dial member 680, the add-on release member 690, and the pen device dial member 480 have been partially cut away to disclose the operation of the internal components during operation of the add-on device, but the housing member protrusion 615 and the dial member protrusion 686 have not been cut away.

[0085] 8A, the add-on device 600 and the pen device 400 are shown in a state where the user has dialed in a dose of 11 IU, thereby taking up all rotational slack in the pen dial mechanism in a clockwise direction and leaving all slack in a counterclockwise direction, with the pen dial member 480 being the first pen component in the series of pen components involved. In the dose setting state shown, the add-on dial member 680 is rotationally coupled to the rotor member 660 via a protrusion 686 of the dial member that engages with a toothed pattern 666, and the rotor member 660 is rotationally coupled to the drive member 650 via a flexible arm follower structure 662 that engages with a proximal portion of a track structure 652 in the drive member 650, so that rotational movement of the add-on dial member 680 can be transferred to the pen dial member 480 to set the dose. In appearance, the "follower" is the active member and the track member is the passive member that is moved. It should be noted that although the rotational force will be transmitted through the flexible arm 661, the introduced flexibility is barely noticeable by the user when setting the dose.

[0086] In a pen dialed up to 11 IU, all slack in the pen dial mechanism will remain counterclockwise. If this is the required dose and an injection is performed at this point, all slack will already be eliminated or absorbed during the dial up and the pen dial member 480 and the drive member 650 will not be able to pivot further clockwise. Thus, the flexible element of the rotor member only induces torque and does not pivot the pen input dial 480, which is absorbed by the flexible arm acting as a torque limiter. The tension in the flexible arm 661 will be released upon dose release when the pen dial is disengaged from the pen reset tube 160, and the pen dial 480 and the drive member 650 will pivot clockwise without affecting any other parts until all tension in the flexible arm is released.

[0087] If instead the dial needs to be turned down to 9 IU instead of the 11 IU dose that was turned (see FIG. 8B), the slack is now lifted in a counterclockwise direction and all slack in the dial mechanism is now left in a clockwise direction. The rotor member 660 is rotationally locked to the add-on dial member 680 while turning the dial both up and down.

[0088] When the dial is turned to the corrected dose of 9 IU, the user starts to move the add-on dose release button 690 in a distal direction. As the rotor member 660 moves axially with the dose release button, the toothed portion 666 starts to slide out of engagement with the protrusion 686 in the dial member, and the protrusion 665 on the distal part of the rotor starts to slide into engagement with the protrusion 615 on the inside of the housing member. See FIG. 8C. Thus, the rotor member 660 is temporarily rotationally connected to both the housing member 610 and the dial member 680, and the rotor member is rotationally locked in the position where it was left when the dose was set. Slack remains in the clockwise direction.

[0089] As the release button 690 moves further distally, the rotor member 660 disengages from the dial member 680, but is still rotationally locked to the housing member 610. The rotor follower structure 662 moves distally into the curved portion of the track structure 652 in the drive member 650, where a torque is induced and the drive member begins to pivot the pen dial member 480 and pick up slack in a clockwise direction.

[0090] If the release button 690 is moved even further distally, the rotor member 660 and the ESA continue to move forward and the induced torque continues to rotate the drive member 650 and the pen dose dial 480 until all slack in the dose setting mechanism in the pen is lifted. If all slack is lifted in the clockwise direction and left in the counterclockwise direction, further rotation of the pen dial 480 is required to move the pen ratchet mechanism and increase the adjusted dose by one unit. However, this requires a significantly larger torque than the rotor member flexible arm 661 can provide. In response, the drive member 650 and the pen dial member 480 stop rotating, so that the flexible arm 661 starts to bend, thus removing the further rotational movement induced by the rotor member 660. See Figures 8D and 8E where the rotor flexible arm 661 is bent, thereby acting as a torque limiter.

[0091] When the ESA engages the pen device dose release button 490, the rotor member 660 disengages from the housing member; that is, the rotor protrusion 665 disengages from the housing protrusion 615. Rotation of the ESA and rotor member 660 is now prevented by friction between the add-on dose release member 690, the rotor member 660, and the ESA. See FIG. 8F.

[0092] Alternatively, the protrusion 665 on the lower part of the rotor member can be made longer so that the rotor member 660 does not disengage from the protrusion 615 of the housing and cannot be rotated before the add-on dose release member 690 is released and the rotor member returns to the starting position engaged with the add-on dial member 680.

[0093] An activation switch on the ESA is actuated and the ESA begins to perform a measurement when the ESA engages the pen dose release button 480 and begins to compress the pen dose release return spring 495. The initial position of the pen reset tube is then established prior to external dosing.

[0094] When the pen dose release button 490 is moved sufficiently distally by the ESA, the pen reset tube 460 disengages from the pen dial member 480, which is then free to rotate. This allows tension built up in the rotor member flexible arm 661 to be released by rotating the drive member 650 and the disengaged pen dial member 480 in a clockwise direction. See FIG. 8G.

[0095] When the reset tube 460 disengages from its connection with the pen device housing, the reset tube begins to rotate counterclockwise when external dosing is initiated. The ESA continues to perform multiple measurements of the angular position of the reset tube during external dosing to establish the number of complete revolutions of the reset tube during external dosing. When external dosing is completed (see FIG. 8H), the reset tube stops at its zero position (or the position where the add-on dose release button 690 is released and external dosing is stopped), and the last measured rotational position of the reset tube when the ESA switch is deactivated is obtained and used as the end position, so that the externally dosed volume can be calculated as described above.

[0096] 9A-9C, a second exemplary embodiment of a locking mechanism suitable for incorporation into an add-on dose logging device of the general type disclosed in FIG. 5B is described.

[0097] FIG. 9A shows an add-on dose logging device 700 comprising an outer assembly and an inner assembly coupled to the outer assembly. The outer assembly comprises a housing member 710 adapted to be coupled to a pen housing, and an add-on dial member 780 rotationally coupled to the housing member 710. The housing is shown with a window 719 for illustrative purposes only. FIG. 9B shows the inner assembly comprising a drive member 750 adapted to non-rotationally engage with the pen device dial member, a combined rotor / button member 760 arranged to transfer rotational movement from the dial member 780 to the drive member 750 during dose setting and to provide locking rotation during dose release, and an electronic sensor assembly (ESA) 770 (see FIG. 9C) disposed within the hollow interior of the rotor / button member 760. In FIG. 9C, an ESA 770 is shown disposed inside the rotor / button member, and a biasing spring 740 is disposed between the ESA and the drive member 750 to provide a return force to the rotor / button member when the latter is moved distally by the user.

[0098] Before describing the operating principle of the add-on device 700, the individual cooperating components will be described in more detail.

[0099] In Fig. 10A, a housing member 710 is shown having a generally tubular configuration. The distal end comprises a coupling means (not shown) adapted to fixedly but releasably engage with a corresponding coupling means on the pen body. The proximal portion comprises a circumferential groove 711 and several axially oriented slots onto which a dial member 780 can be snapped. The inner surface of the housing member comprises a proximally disposed circumferential array of protrusions 715 adapted to engage corresponding protrusions on a rotor / button member 760 during operation, as well as a circumferential proximally facing edge 713 for rotationally supporting the drive member 750 during dose setting. The housing is shown with a window 719 for illustrative purposes only.

[0100] The generally cylindrical dial member 780 shown in Fig. 10B comprises an inner circumferential ridge 781 adapted to be rotatable in both directions about a central axis whilst being axially fixed within the groove 711 of the housing member. The proximal portion comprises a circumferential wall portion 782 surrounding a circular opening 783 adapted to receive a proximal portion of the rotor / button member 760. On a distal surface of the circumferential wall portion is provided a toothed portion 786 adapted to engage a corresponding protrusion on the rotor / button member 760 and transfer rotational movement from the dial member 780 to the rotor / button member during dose setting.

[0101] The generally cylindrical rotor / button member 760 shown in FIG. 10C comprises a proximal button portion 769 having a diameter corresponding to the dial member opening 783, and a distally extending generally cylindrical rotor / skirt portion having a larger diameter. The skirt portion comprises several (here, three) circumferentially extending flexible fingers 761 each having an outwardly oriented projection 765 at a free end adapted to engage with the circumferential housing toothed portion 715, thereby providing a torque limiter, described in more detail below. The rotor / button member 760 comprises several (here, three) circumferentially disposed proximally extending projections 766 adapted to engage and disengage from the dial member toothed portion 786 during operation. At the distal end, the rotor portion comprises several (here three) curved / non-linear slots / races 762 adapted to receive and axially guide the drive member followers 752 .

[0102] The drive member 750 shown in Fig. 10D comprises a generally cylindrical main portion 755 from which extend distally a number of axially oriented drive fingers 758 adapted to engage with the pen dial grooves 488, thereby rotationally locking the drive member to the pen dial member 480. A number of (here, three) arms 751 extend axially proximally, each arm comprising an outwardly projecting generally cylindrical follower structure 752 adapted to engage with a corresponding slot / race structure 762 of the drive member 760. The main portion further comprises a number of circumferentially arranged guide structures 753 adapted to slidingly engage with the inner wall surface of the housing as well as with a proximally oriented support surface of the circumferential edge 713, thereby ensuring centering of the drive member within the housing during rotational movement. The ESA (see FIG. 9C) includes an axially oriented slot adapted to receive the arm therein to rotationally couple the ESA to the drive member.

[0103] The operation of the add-on device 700 will be described with reference to FIGS. 11A to 11E.

[0104] Generally, all of Figures 11A-11E show, in a partially cut-away view, the add-on device 700 of Figure 9A mounted on the pen-type drug delivery device 400 of Figure 5A, with the add-on housing member 710 mounted on the pen housing 410 and the add-on driver 750 rotationally coupled to the pen dial member 480 via distally extending fingers 758.

[0105] More specifically, it should be noted that the housing member 710 and the add-on dial member 780 have been partially cut away to disclose the operation of the internal components during operation of the add-on device, but the protrusion 715 of the housing member has not been cut away.

[0106] The basic operating principle of the second embodiment is the same as that of the first embodiment, and when the add-on dose release button is actuated, a torque in the counterclockwise direction (turning the dial up) is always applied to the input dial member of the pen-type device. In this way, regardless of the size of the actual slack in a particular device, or whether the user turned the dial up or down just before external dosing, any slack will always be left on the same side. If the actual slack is less than the attempted compensation, or if the user turned the dial up just before injection, the torque limiter between the add-on housing and the rotor / button member will come into operation and slip. Thus, instead of turning the dial up on the device by one unit, the rotor / button member will skip one or more clicks of the rotation torque limiter and rotate the drive member counterclockwise instead of turning it further clockwise.

[0107] An add-on dose release button is incorporated into the rotor in a second embodiment. When the dose release button is pressed, the rotor / button member orbits downwards, which induces a torque on the drive member, causing the drive member to pivot the input dial of the injection device in a clockwise direction (turning the dial up) and pick up any slack.

[0108] The protrusions on the top edge of the rotor / button member and the teeth in the dial member are to allow the rotor / button member, and thus the drive member, to be manipulated by the add-on input dial member 780 during dose sizing. The protrusions 765 on the flexible fingers 761 on the rotor / button member and the protrusions 715 in the housing member 710 are designed to rotationally lock the rotor / button to the add-on housing during axial actuation of the dose release button, i.e. until a given amount of torque is generated. In this case the "lock" will jump to the next protrusion.

[0109] 11A, the add-on device 700 and the pen device 400 are shown with the dial initially turned, for example, a dose of 11 IU, dialed down to 9 IU. Thus, initially, all rotational slack in the pen dial mechanism is taken up in the clockwise direction, and all slack is left in the counterclockwise direction. However, when the dial is turned down to 9 IU, all slack in the dial mechanism is left in the clockwise direction. During turning the dial both up and down, the add-on dial member 780 is rotationally coupled to the rotor / button member 760 via the toothed pattern 786 of the dial member that engages with the protrusion 766, and the rotor / button member 760 is rotationally coupled to the drive member 750 via the arm follower structure 752 that engages with the distal portion of the track structure 762 in the rotor / button member 760, so that the rotational movement of the add-on dial member 780 can be transferred to the pen dial member 480 to set or adjust the dose.

[0110] When the corrected 9 IU dose has been dialed, the user begins to move the rotor / button member 760 distally by depressing it onto the release button portion 769. See FIG. 11B. As the rotor / button member begins to move distally, the rotor projection 766 begins to disengage from the dial member toothed portion 786 and the projection 765 on the flexible finger 761 begins to slide into engagement with the circumferential projection 715 on the inside of the housing member 710. Thus, the rotor / button member 760 is temporarily rotationally connected to both the housing member and the dial member and is thus rotationally locked in the position where it was left when the dose was set.

[0111] 11C, as the rotor / button member 760 is moved further distally, it disengages from the dial member 780, but is still rotationally locked to the housing member 710. A torque is now induced in the drive member 750 by the drive member follower 752 disposed within the curved track 762 of the axially moving rotor / button member, which causes the drive member 750 to pivot the pen device dial member 480 and begin to pick up slack in a clockwise direction.

[0112] During continued actuation of the release button portion 769, the rotor / button member 760 and the ESA coupled to the rotor / button member 760 continue to move distally as shown in FIG. 11D, which causes increasing torque to be applied to the drive member as the drive member follower 752 moves laterally on the non-axial portion of the rotor track 762, which continues to turn the pen device dial member 480 and lift slack in a clockwise direction. However, when the torque transmission limit between the finger projections 765 and the housing projections 715 is reached, the rotational lock is disengaged as the flexible fingers 761 deflect inward, causing the rotor projections to "jump" one notch on the housing teeth 715. This limit needs to be designed such that the slack is lifted within a safe margin of worst case magnitude.

[0113] If less slack exists in the actual device than in the worst case, or if the device dial is turned up instead of down, all slack will be lifted in a clockwise direction just prior to actuation of the rotor / button member 760, and left in a counterclockwise direction before the rotation lock is disengaged. In this case, further rotation of the pen device dial member 480 is required to move the ratchet mechanism and increase the adjusted dose by one unit.

[0114] However, this requires significantly more torque than the rotational lock of the rotor / button member's flexible fingers 761 can support, and instead causes the protrusions 765 on the rotor / button member's flexible elements to deflect inward. This causes the rotor / button member 760 to rotate counterclockwise one or more clicks to compensate for the clockwise rotation of the drive member 750 relative to the rotor / button member. This causes the rotor / button member to rotate counterclockwise an integer number of clicks, so the drive member's dial may be turned slightly counterclockwise and a small amount of slack re-introduced in the clockwise direction.

[0115] However, the rotor / button member 760 will simply skip a click as long as the orbit of the rotor / button member induces a torque on the drive member 750 while the protrusions of the rotor / button member are engaged with the teeth / protrusions in the housing. Thus, any small counterclockwise rotation of the drive member caused by a clickback of the rotor / button member 760 will be immediately followed by a resumption of clockwise rotation which picks up any slack that was reintroduced.

[0116] When the ESA engages the pen dose release button 490 and begins to compress the pen dose release button return spring, an activation switch on the ESA is tripped and the ESA begins to perform measurements to determine the initial rotational position of the pen reset tube prior to external dosing. When the pen dose release button 490 is moved sufficiently distally by the ESA, the pen reset tube 460 disengages from the pen dial member 480, which is then free to rotate. This allows any tension built up in the torque limiter to be released by rotating the drive member 750 and the disengaged pen dial member 480 in a clockwise direction.

[0117] When the pen device reset tube disengages from its connection with the pen device housing, the reset tube begins to rotate counterclockwise when external dosing is initiated. The ESA continues to perform multiple measurements of the angular position of the reset tube during external dosing to establish the number of complete revolutions of the reset tube during external dosing. When external dosing is completed (see FIG. 11E), the reset tube stops at its zero position (or the position where the add-on dose release button 769 is released and external dosing is stopped), and the last measured rotational position of the reset tube when the ESA switch is deactivated is obtained and used as the end position, so that the externally dosed volume can be calculated as described above.

[0118] When the user releases pressure on the dose release button portion 769, the rotor / button member 760 and ESA return to their initial proximal positions by the return spring 740 shown in FIG. 9C.

[0119] In FIG. 12, the add-on device 700 and pen device 400 of FIG. 11A are shown in a different view in which the rotor / button member 760 and drive member 750 have been partially cut away to clearly show the ESA 770, return spring 740, pen dial groove 488, and pen device release member 490.

[0120] In the above description of the exemplary embodiments, different structures and means for providing the described functionality for the different components have been described to the extent that the concept of the invention is clear to those skilled in the art. The detailed construction and specification for the different components are considered to be the subject of normal design procedures carried out by those skilled in the art along the lines described herein.

Claims

1. An add-on device (600, 700) adapted to be releasably mounted on a drug delivery device (100, 400), said drug delivery device comprising: a housing (410) defining a reference axis; a drug reservoir or means for receiving a drug reservoir, - a drug discharge means, said drug discharge means comprising: - a dose setting member (480) adapted to be rotated in a first direction to incrementally set a dose and to be rotated in an opposite second direction to incrementally reduce the set dose, said dose setting member (480) being arranged at the proximal end of said housing; a release member (490) actuatable between a proximal position and a distal position, said proximal position allowing the dosage to be set and said distal position enabling said drug ejection means to eject the set dose, The add-on device, - an add-on housing (610, 710) adapted to be releasably attached to said medication delivery device housing in an axially and rotationally immovable position; - a drive member (650, 750) adapted to be rotationally locked and mounted on said dose setting member (480); an add-on dose setting member (680, 780) that is freely rotatable but axially locked and connected to said add-on housing and adapted to be rotated in said first direction to set a dose and to be rotated in said opposite second direction to decrease the set dose; - an actuatable add-on release member (690, 760, 769) axially rotatable relative to said add-on dose setting member between (i) a proximal dose setting position and (ii) a distal dose ejection position, in said proximal dose setting position, said add-on dose setting member (680, 780) is operable to rotate said drive member (650, 750) and thereby set a dose when mounted on said dose setting member (480); and an actuatable add-on release member (690, 760, 769) which, in the distal dose ejection position, moves to a distal position of the release member (490) to release a set dose when the add-on device is mounted on the medication delivery device; a linear-to-rotary converter mechanism adapted to convert an axial movement of the add-on release member into a rotational movement of the drive member (650, 750) in the first direction when the add-on release member moves from the proximal position towards the distal position, Thereby, when the add-on device (600, 700) is mounted on the drug delivery device (100, 400), - an add-on device (600, 700), wherein the dose setting member (480) is biased in the first direction by the drive member (650, 750) when the add-on release member moves from the proximal position towards the distal position.

2. The add-on device of claim 1, further comprising a torque limiter, the torque limiter preventing a torque above a preset level from being transmitted to the drive member when moving the add-on release member from the proximal position towards the distal position when the add-on device (600, 700) is mounted on the drug delivery device (100, 400).

3. The torque limiter, - comprising a flexible element adapted to deform when a torque exceeding said preset level is transmitted to said drive member, or An add-on device according to claim 2 in the form of a ratchet torque limiter.

4. An add-on device according to any one of claims 1 to 3, wherein the rotational movement is generated by a cam-follower mechanism.

5. The cam-follower mechanism comprises:

5. The add-on device of claim 4, comprising a track (652, 762) and a follower (662, 752) disposed within the track, the track having a radial component, the follower and track moving axially relative to each other as the add-on release member moves from the proximal position toward the distal position.

6. The add-on device of claim 5 , wherein the follower comprises a flexible arm (661) adapted to bend when a torque above a preset level is imparted to the drive member.

7. The drug discharge means (400) - an indicator (460) adapted to rotate during the ejection of a dose, the amount of rotation indicating the size of said ejected dose, The add-on device, - comprising sensor means (670, 770) operable to detect said amount of rotation of said indicator during ejection of a dose, - before said sensor means are operated, a rotational movement is applied to said drive member, As a result, - An add-on device according to any one of claims 1 to 6, wherein when the add-on device is mounted on the drug delivery device, it is ensured that rotational slack of the drug ejection means is removed by rotation of the dose setting member in the first direction.

8. 8. The add-on device of claim 7, further comprising an actuator structure adapted to move axially and engage with the release member (490) when the add-on release member is actuated, and wherein the sensor means (670, 770) is coupled to the actuator structure and moves axially therewith.

9. 10. An assembly comprising a drug delivery device as defined in claim 1 and an add-on device as defined in any one of claims 1 to 6.

10. 9. An assembly comprising a drug delivery device as defined in claim 7 and an add-on device as defined in claim 7 or 8.

11. - said indicator comprises a plurality of dipole magnets, said sensor means (670, 770), a number of magnetometers, disposed in a non-rotational orientation relative to said housing in a mounted state and adapted to determine values ​​of the magnetic field from said number of dipole magnets; An assembly as claimed in claim 10, comprising: - processor means configured to determine a rotational position and / or a rotational movement of said indicator based on measurements from said plurality of magnetometers.

12. - said drug ejection means (400) comprises an indicator (460) adapted to rotate during the ejection of a dose, the amount of rotation indicating the size of said ejected dose; - an assembly comprising a drug delivery device as defined in claim 1 and an add-on device as defined in any one of claims 1 to 6, wherein said drug delivery device is adapted to mount a dose logging add-on device comprising sensor means operable to detect the amount of rotation of said indicator during ejection of a dose.

13. - said drug ejection means (400) comprises an indicator (460) adapted to rotate during ejection of a dose, said amount of rotation being indicative of said size of said ejected dose, - an assembly comprising a drug delivery device as defined in claim 1 and an add-on device as defined in any one of claims 1 to 6, wherein the assembly further comprises a dose logging add-on device adapted to be mounted on said drug delivery device, said dose logging add-on device comprising sensor means operable to detect the amount of rotation of said indicator during ejection of a dose.

14. - said indicator comprises a plurality of dipole magnets, said sensor means (670, 770), a number of magnetometers, disposed in a non-rotational orientation relative to said housing in a mounted state and adapted to determine values ​​of the magnetic field from said number of dipole magnets; An assembly as claimed in claim 13, comprising: - processor means configured to determine a rotational position and / or a rotational movement of said indicator based on measurements from said plurality of magnetometers.

15. 1. An integrated drug delivery device comprising: a housing defining a reference axis; a drug reservoir or means for receiving a drug reservoir, - a drug discharge means, an inner dose setting member adapted to be rotated in a first direction to set a dose and to be rotated in an opposite second direction to decrease the set dose; an inner release member actuatable between a proximal position and a distal position, said proximal position allowing the dosage to be set and said distal position enabling said drug ejection means to eject the set dose; and - drug ejection means comprising an indicator adapted to rotate during ejection of a dose, the amount of rotation indicating the size of said ejected dose; a user dose setting member that is freely rotatable but axially locked and connected to said housing and adapted to be rotated in said first direction to set a dose and to be rotated in said opposite second direction to decrease the set dose; - an actuatable user release member that is axially rotatable relative to said user dose setting member between (i) a proximal dose set position and (ii) a distal dose ejection position, in which said user dose setting member is operable to rotate said inner dose setting member to set a dose, and in which said distal dose ejection position said inner release member moves to a position distal to said inner release member to release the set dose; - a linear-to-rotary converter mechanism adapted to convert axial movement of the user release member into rotational movement of the inner dose setting member in the first direction when the user release member moves from the proximal position towards the distal position.

Citation Information

Patent Citations

  • Cam apparatus and camera

    JP2004341466A

  • A drug dispensing injection pen with an add-on medication acquisition / display module.

    JP2014520583A

  • Drive mechanism for drug delivery device and drug delivery device

    JP2019051388A

  • Injection Device with Electronic Detecting Means

    US20090318865A1

  • Electronically assisted drug delivery device

    WO2010052275A2